BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22442244)

  • 1. Purification, crystallization and preliminary X-ray diffraction analysis of the Fyn SH2 domain and its complex with a phosphotyrosine peptide.
    Huculeci R; Buts L; Lenaerts T; van Nuland NA; Garcia-Pino A
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Mar; 68(Pt 3):359-64. PubMed ID: 22442244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H, 13C and 15N backbone and side-chain chemical shift assignment of the Fyn SH2 domain and its complex with a phosphotyrosine peptide.
    Huculeci R; Buts L; Lenaerts T; van Nuland NA
    Biomol NMR Assign; 2011 Oct; 5(2):181-4. PubMed ID: 21298565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into the intertwined dimer of fyn SH2.
    Huculeci R; Garcia-Pino A; Buts L; Lenaerts T; van Nuland N
    Protein Sci; 2015 Dec; 24(12):1964-78. PubMed ID: 26384592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn.
    Panchamoorthy G; Fukazawa T; Stolz L; Payne G; Reedquist K; Shoelson S; Songyang Z; Cantley L; Walsh C; Band H
    Mol Cell Biol; 1994 Sep; 14(9):6372-85. PubMed ID: 7520528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity.
    Mulhern TD; Shaw GL; Morton CJ; Day AJ; Campbell ID
    Structure; 1997 Oct; 5(10):1313-23. PubMed ID: 9351806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Characterization of Monomeric/Dimeric State of p59
    Huculeci R; Kieken F; Garcia-Pino A; Buts L; van Nuland N; Lenaerts T
    Methods Mol Biol; 2017; 1555():257-267. PubMed ID: 28092037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical shift assignments of the partially deuterated Fyn SH2-SH3 domain.
    Kieken F; Loth K; van Nuland N; Tompa P; Lenaerts T
    Biomol NMR Assign; 2018 Apr; 12(1):117-122. PubMed ID: 29224116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting the phosphotyrosine binding pocket of Fyn SH2 domain led to the identification of novel SH2 superbinders.
    Li S; Zou Y; Zhao D; Yin Y; Song J; He N; Liu H; Qian D; Li L; Huang H
    Protein Sci; 2021 Mar; 30(3):558-570. PubMed ID: 33314411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution structural analysis shows how different crystallographic environments can induce alternative modes of binding of a phosphotyrosine peptide to the SH2 domain of Fer tyrosine kinase.
    Matsuura Y
    Protein Sci; 2019 Nov; 28(11):2011-2019. PubMed ID: 31441171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raf-1 interacts with Fyn and Src in a non-phosphotyrosine-dependent manner.
    Cleghon V; Morrison DK
    J Biol Chem; 1994 Jul; 269(26):17749-55. PubMed ID: 7517401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study.
    Charifson PS; Shewchuk LM; Rocque W; Hummel CW; Jordan SR; Mohr C; Pacofsky GJ; Peel MR; Rodriguez M; Sternbach DD; Consler TG
    Biochemistry; 1997 May; 36(21):6283-93. PubMed ID: 9174343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of p59(fyn) with the T lymphocyte costimulatory receptor CD2. Binding of the Fyn Src homology (SH) 3 domain is regulated by the Fyn SH2 domain.
    Lin H; Hutchcroft JE; Andoniou CE; Kamoun M; Band H; Bierer BE
    J Biol Chem; 1998 Jul; 273(31):19914-21. PubMed ID: 9677430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
    Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J
    Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual fatty acylation of p59(Fyn) is required for association with the T cell receptor zeta chain through phosphotyrosine-Src homology domain-2 interactions.
    van't Hof W; Resh MD
    J Cell Biol; 1999 Apr; 145(2):377-89. PubMed ID: 10209031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Targeting of SH2 Domain-Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies.
    Kükenshöner T; Schmit NE; Bouda E; Sha F; Pojer F; Koide A; Seeliger M; Koide S; Hantschel O
    J Mol Biol; 2017 May; 429(9):1364-1380. PubMed ID: 28347651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure and NMR studies of the apo SH2 domains of ZAP-70: two bikes rather than a tandem.
    Folmer RH; Geschwindner S; Xue Y
    Biochemistry; 2002 Dec; 41(48):14176-84. PubMed ID: 12450381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.
    Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER
    Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.